NCT04001543View on ClinicalTrials.gov

Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 14, 2019

Primary Completion Date

March 2, 2021

Study Completion Date

May 31, 2026

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DIETARY_SUPPLEMENT

Immunomodulating oral supplementation

Per os administration, 3 times / day, 5 days before each cycle of chemotherapy.

DIETARY_SUPPLEMENT

Sip feed control

Per os administration, 3 times / day, 5 days before each cycle of chemotherapy.

Trial Locations (2)

34298

Institut du Cancer de Montpellier, Montpellier

69373

Centre Léon Bérard, Lyon

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT04001543 - Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer | Biotech Hunter | Biotech Hunter